<DOC>
	<DOCNO>NCT01319110</DOCNO>
	<brief_summary>Specific Aim # 1 : To determine level CoQ10 low post-cardiac arrest ( CA ) . We perform prospective trial primary endpoint describe prevalence low serum CoQ10 level . Specific Aim # 2 : To determine CoQ10 level post-CA patient increase administration exogenous CoQ10.. We perform randomize control trial ( RCT ) post-CA patient secondary endpoint compare CoQ10 level among randomized CoQ10 supplementation v placebo .</brief_summary>
	<brief_title>Coenzyme Q10 Post-Cardiac Arrest Cerebral Resuscitation</brief_title>
	<detailed_description>Cardiac arrest ( CA ) occur nearly 350,000 patient U.S. year estimate mortality 60 % survive initial arrest . Moreover , overall prognosis survivor often limit neurologic injury . Two randomize control trial ( RCTs ) demonstrate therapeutic hypothermia ( TH ) CA improve survival reduces neurologic morbidity . As result study , TH become standard care post-CA patient . The mechanism action TH hypothesize reduction cerebral oxygen consumption occur follow ischemia-reperfusion injury . Another similar potential target follow ischemia-reperfusion injury mitochondrial function injure brain cell attenuation potentially damaging oxygen-free radical . Specifically , optimize mitochondrial function reduce oxygen free radical may enhance cellular function mitigate cellular injury thereby lead improve neurologic outcome . Coenzyme Q10 ( CoQ10 ) essential mitochondrial co-factor free radical scavenger find neuroprotective effect various neurodegenerative disorder Parkinson 's disease Huntington 's disease . Whether CoQ10 provide neuroprotection acute ischemia-reperfusion injury remain less clear , recognize American Heart Association potentially promise neuroprotective agent . We hypothesize administration exogenous CoQ10 raise serum concentration CoQ10 may mitigate adverse effect post-CA ischemia-reperfusion injury brain optimize mitochondrial function reduce oxygen-free radical . We support hypothesis following : 1 . Ischemia-reperfusion injury disrupts normal mitochondrial function increase O2 free radical . 2 . CoQ10 find attenuate effect ischemia-reperfusion injury optimize mitochondrial function mitigation cellular apoptosis . 3 . CoQ10 neuroprotective effect neurodegenerative disorder . 4 . Our group unpublished preliminary data show low CoQ10 level majority patient septic shock , low CoQ10 level significantly associate multiple marker inflammatory cascade . 5 . A pilot human trial post-CA patient demonstrate reduction mortality trend toward reduction neurologic morbidity . To test hypothesis , propose follow pilot study proof concept preparation large multicenter trial power toward neurologic outcome mortality . This pilot study allow inform power analysis large trial , provide proof concept enrollment administration therapy , examine time-frame drug absorption serum , evaluate tolerability .</detailed_description>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>1 . Adult patient ( age &gt; 18 year ) 2 . Comatose CA subsequent return spontaneous circulation 1 . Comatose status prior CA 2 . CoQ10 therapy within one month prior CA 3 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cardiac Arrest</keyword>
	<keyword>Post Cardiac Arrest</keyword>
	<keyword>CoQ10</keyword>
	<keyword>Ubiquinone</keyword>
	<keyword>Post Arrest</keyword>
</DOC>